Sectors
CLDX
Celldex Therapeutics, Inc.
33.96
1 x 33.87
1 x 34.01
bid
ask
-
1.70
4.77%
10:02 AM
timesize
| Ytd | 25.04% | |
| 1y | 51.88% |
33.83
day range
36.09
19.72
52 week range
40.30
| Open | 33.83 | Prev Close | 35.66 | Low | 33.83 | High | 36.09 | Mkt Cap | 2.37B |
| Vol | 574.04K | Avg Vol | 948.69K | EPS | -4.26 | P/E | -8.37 | Forward P/E | -8.69 |
| Beta | 0.90 | Short Ratio | 5.97 | Inst. Own | 95.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 33.40 | 200-d Avg | 29.26 | 1yr Est | 57.53 |
| Income Statement | |||
| Total Revenue | 15.00K | ||
| Revenues (USD) | 15.00K | ||
| Gross Profit | 15.00K | ||
| Operating Expenses | 84.45M | ||
| Research and Development Expense | 73.00M | ||
| Selling, General and Administrative Expense | 11.45M | ||
| Operating Income | -84.43M | ||
| Net Income | -78.68M | ||
| Net Income Common Stock | -78.68M | ||
| Net Income Common Stock (USD) | -78.68M | ||
| Consolidated Income | -78.68M | ||
| Earnings per Basic Share | -1.18 | ||
| Earnings per Basic Share (USD) | -1.18 | ||
| Earnings per Diluted Share | -1.18 | ||
| Earning Before Interest & Taxes (EBIT) | -78.68M | ||
| Earning Before Interest & Taxes (USD) | -78.68M | ||
| Weighted Average Shares | 66.57M | ||
| Weighted Average Shares Diluted | 66.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 35.73M | ||
| Cash and Equivalents (USD) | 35.73M | ||
| Investments | 415.73M | ||
| Investments Current | 415.73M | ||
| Trade and Non-Trade Receivables | 230.00K | ||
| Current Assets | 459.22M | ||
| Property, Plant & Equipment Net | 9.41M | ||
| Total Assets | 511.25M | ||
| Debt Current | 1.47M | ||
| Total Debt | 1.91M | ||
| Current Liabilities | 51.47M | ||
| Debt Non-Current | 443.00K | ||
| Total Liabilities | 55.03M | ||
| Accumulated Retained Earnings (Deficit) | -1.89B | ||
| Accumulated Other Comprehensive Income | 2.52M | ||
| Shareholders Equity | 456.23M | ||
| Shareholders Equity (USD) | 456.23M | ||
| Assets Non-Current | 52.03M | ||
| Total Debt (USD) | 1.91M | ||
| Goodwill and Intangible Assets | 27.19M | ||
| Liabilities Non-Current | 3.56M | ||
| Trade and Non-Trade Payables | 10.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 854.00K | ||
| Net Cash Flow from Financing | 327.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.86M | ||
| Capital Expenditure | -1.64M | ||
| Issuance (Purchase) of Equity Shares | 327.00K | ||
| Net Cash Flow from Investing | 72.12M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 73.76M | ||
| Net Cash Flow from Operations | -65.59M | ||
| Share Based Compensation | 8.52M | ||